RTSN logo

Retension Pharmaceuticals Inc.

RTSN
Healthcare|Medical - Pharmaceuticals|US
$11.04
+0.32 (+2.99%)

Ownership Breakdown

3.8M
Shares Outstanding

Major Holders (6)

Combined: 52.8%

Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.

HolderType% of ClassSharesFiledFiling
B Group Capital LLCOther10.00%833,333Oct 16, 202613D/G
The B Group, Inc.IA, HC10.00%833,333Oct 16, 202613D/G
Branden B. MuhlHC, IN10.00%833,333Oct 16, 202613D/G
PVG Asset Management CorpIV, IA, CO8.30%1,002,050Oct 16, 202613D/G
Laurence W. LyttonIndividual7.40%617,207Oct 15, 202613D/G
Eric KellerIndividual7.07%598,598Oct 14, 202613D/G

Insider Trades (29)

Last 4 quarters: 434,125 acquired · 76,631 disposed
InsiderPositionDateTypeSharesPriceValueFiling
Wong RobertVP, Chief Accounting OfficerNov 2, 2026AWARD25,000$11.30$282.5KForm 4
Wong RobertofficerNov 2, 2026OTHER0——Form 4
Keller Eric L.director, officer: CHIEF EXECUTIVE OFFICEROct 22, 2026AWARD40,884$15.50$633.7KForm 4
B Group, Inc.10 percent ownerOct 13, 2026OTHER0——Form 4
Keller Eric L.director, officer: CHIEF EXECUTIVE OFFICEROct 13, 2026CONVERSION31,368——Form 4
Keller Eric L.director, officer: CHIEF EXECUTIVE OFFICEROct 13, 2026CONVERSION9,662——Form 4
Keller Eric L.director, officer: CHIEF EXECUTIVE OFFICEROct 13, 2026BUY20,800$12.00$249.6KForm 4
Keller Eric L.director, officer: CHIEF EXECUTIVE OFFICEROct 13, 2026AWARD255,174$11.63$3.0MForm 4
Keller Eric L.director, officer: CHIEF EXECUTIVE OFFICEROct 13, 2026CONVERSION9,662——Form 4
Keller Eric L.director, officer: CHIEF EXECUTIVE OFFICEROct 13, 2026CONVERSION31,368——Form 4
Sweetnam PaulCHIEF SCIENTIFIC OFFICEROct 13, 2026CONVERSION4,026——Form 4
Sweetnam PaulCHIEF SCIENTIFIC OFFICEROct 13, 2026CONVERSION2,640——Form 4
Sweetnam PaulCHIEF SCIENTIFIC OFFICEROct 13, 2026CONVERSION4,026——Form 4
Sweetnam PaulCHIEF SCIENTIFIC OFFICEROct 13, 2026CONVERSION2,640——Form 4
Olds DonalddirectorOct 13, 2026CONVERSION5,637——Form 4
Olds DonalddirectorOct 13, 2026CONVERSION5,637——Form 4
Cheruvu PavandirectorOct 13, 2026AWARD5,636$11.63$65.5KForm 4
Bisson SabineCHIEF OPERATING OFFICEROct 13, 2026CONVERSION2,504——Form 4
Bisson SabineCHIEF OPERATING OFFICEROct 13, 2026CONVERSION1,611——Form 4
Bisson SabineCHIEF OPERATING OFFICEROct 13, 2026CONVERSION1,611——Form 4
Bisson SabineCHIEF OPERATING OFFICEROct 13, 2026CONVERSION2,504——Form 4
BERGER FRANKLIN MdirectorOct 13, 2026CONVERSION12,517——Form 4
BERGER FRANKLIN MdirectorOct 13, 2026BUY10,000$12.00$120.0KForm 4
BERGER FRANKLIN MdirectorOct 13, 2026CONVERSION12,517——Form 4
BERENDT MICHAEL JdirectorOct 13, 2026CONVERSION2,640——Form 4
BERENDT MICHAEL JdirectorOct 13, 2026CONVERSION4,026——Form 4
BERENDT MICHAEL JdirectorOct 13, 2026CONVERSION4,026——Form 4
BERENDT MICHAEL JdirectorOct 13, 2026CONVERSION2,640——Form 4
Cheruvu Pavandirector: Oct 13, 2026OTHER0——Form 4